ASTRAZENECA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.9 USD | -0.18% |
|
-0.36% | +14.18% |
| May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| May. 16 | AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AZN Stock
- AZN Stock
- Charts AstraZeneca PLC
